Document ID: chunk:federal_register_of_legislation:F2024L01153:body:0:p15
Version: federal_register_of_legislation:F2024L01153
Segment Type: other
Provision Reference: 
Character Range: 40713–43748

sales mentioned in paragraph (a) represent more than one half of the total amount of that special medical purpose product for infants sold by the person during that 24 month period.

            medical practitioner means a person registered or licensed as a medical practitioner under legislation in Australia or New Zealand, as the case requires, for the registration or licensing of medical practitioners.

           2.9.1—32 General compositional requirements

            (1) A special medical purpose product for infants must have an energy content of no less than 2510 kJ/L and no more than 2930 kJ/L.

            (2) Subject to subsections (3) and (4), a special medical purpose product for infants must not contain added fructose and/or added sucrose.

            (3) A special medical purpose product for infants manufactured from partially hydrolysed protein may contain added fructose and/or added sucrose, provided that:

                (a) the fructose and/or sucrose is added to the product to provide a source of carbohydrate; and
               (b) the sum of the fructose and/or sucrose in the product does not exceed 20% of available carbohydrates in the product.
            (4) Subsection (2) does not apply to added fructose and/or added sucrose that is present in a special medical purpose product for infants as a result of:
               (a) the addition of *inulin-type fructans to the product in accordance with this Standard; and/or
               (b) the use of a substance as a processing aid in accordance with this Code in the manufacture of the product.

            (5) The fluoride content of a special medical purpose product for infants must not exceed:

               (a) if in a powdered or concentrated form—17 μg/100 kJ; and
               (b) if in a 'ready-to-drink' form—24 μg/100 kJ.
            (6)  The amounts in subsection (5) apply to the special medical purpose product for infants as sold.

           2.9.1—33 Protein requirements

            (1) A special medical purpose product for infants must be only derived from one or more of the following proteins:

                (a) cow milk;
               (b) goat milk;
               (c) sheep milk;
               (d) soy protein isolate;

               (e) a partially hydrolysed protein of one or more of the above.

            (2) A special medical purpose product for infants must have a protein content of:
               (a) for a milk-based product—no less than 0.43 g/100 kJ and no more than 0.72 g/100 kJ; and
               (b) for a product that is not milk-based product—no less than 0.54 g/100 kJ and no more than 0.72 g/100 kJ.

            (3) For the purposes of subsection (2), milk-based product means a special medical purpose product for infants that is derived only from one or more of the following proteins: cow milk; goat milk; sheep milk; a partially hydrolysed protein of one or more of cow milk, goat milk and sheep milk.

            (4) The L-amino acids listed in the table to section S29—3